Results 11 to 20 of about 78,032 (168)

Immune Thrombocytopenic Purpura in a Patient with Covid-19

open access: yesNew England Journal of Medicine, 2020
Immune Thrombocytopenic Purpura and Covid-19 Immune thrombocytopenia with lower-extremity purpura, mucosal bleeding, and cerebral microhemorrhage developed during the clinical course in a 65-year-o...
A. Zulfiqar   +3 more
semanticscholar   +1 more source

ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura

open access: yesJournal of Thrombosis and Haemostasis, 2020
Despite an increase in our understandings of pathogenesis of thrombotic thrombocytopenic purpura (TTP), the approaches for initial diagnosis and management of TTP vary significantly.
X. L. Zheng   +13 more
semanticscholar   +1 more source

ISTH guidelines for treatment of thrombotic thrombocytopenic purpura

open access: yesJournal of Thrombosis and Haemostasis, 2020
Despite advances in treatment options for thrombotic thrombocytopenic purpura (TTP), there are still limited high quality data to inform clinicians regarding its appropriate treatment.
X. L. Zheng   +13 more
semanticscholar   +1 more source

Idiopathic Thrombocytopenic Purpura

open access: yesDefinitions, 2020
Five patients with idiopathic thrombocytopenic purpura (ITP) associated with malignant lymphoma are presented, and twelve other cases reported in the literature are reviewed. Thirteen patients (76%) had Hodgkin's disease; two had diffuse histiocytic, one,
K. Fink
semanticscholar   +1 more source

Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura

open access: yesJournal of Thrombosis and Haemostasis, 2020
Despite advances in treatment options for thrombotic thrombocytopenic purpura (TTP), there are still limited high quality data to inform clinicians regarding its management.
X. L. Zheng   +13 more
semanticscholar   +1 more source

Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura

open access: yesNew England Journal of Medicine, 2019
BACKGROUND In acquired thrombotic thrombocytopenic purpura (TTP), an immune‐mediated deficiency of the von Willebrand factor–cleaving protease ADAMTS13 allows unrestrained adhesion of von Willebrand factor multimers to platelets and microthrombosis ...
M. Scully   +12 more
semanticscholar   +1 more source

A case of immune thrombocytopenic purpura presenting with intracranial hemorrhage

open access: yesJournal of Acute Disease, 2013
Immune thrombocytopenic purpura is an acute, generally considered a self-limiting benign disorder with a 60%-80% change of spontaneous recovery occurring usually within a few months after onset.
Sinan Akbayram   +5 more
doaj   +1 more source

Hereditary thrombotic thrombocytopenic purpura

open access: yesHaematologica, 2019
The first description of thrombotic thrombocytopenic purpura (TTP) by Moschowitz was published nearly 100 years ago.[1][1] This was likely to have been an immune-mediated TTP episode and the author described multi organs affected with worsening ...
M. Scully
semanticscholar   +2 more sources

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.

open access: yesBlood, 2009
Diagnosis and management of immune thrombocytopenic purpura (ITP) remain largely dependent on clinical expertise and observations more than on evidence derived from clinical trials of high scientific quality.
F. Rodeghiero   +19 more
semanticscholar   +1 more source

Thrombotic Thrombocytopenic Purpura in Dengue Fever

open access: yesActa Medica Indonesiana, 2021
Thrombotic thrombocytopenic purpura is a rare but life threatening medical condition. Early recognition and treatment of thrombotic thrombocytopenic purpura is important especially in patients who do not present with the classic pentad to reduce the high
Tze Yuan Tee, Rizna Abdul Cader
doaj  

Home - About - Disclaimer - Privacy